Literature DB >> 16638247

The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure.

Ahmet Fuat1, Jeremy J Murphy, A Pali S Hungin, Jane Curry, Ali A Mehrzad, Andrew Hetherington, Jennifer I Johnston, W Stuart A Smellie, Victoria Duffy, Patricia Cawley.   

Abstract

BACKGROUND: National guidelines suggest the use of natriuretic peptides in suspected heart failure but there have been no studies comparing assays in primary care. AIM: To test and compare the diagnostic accuracy and utility of B-type natriuretic peptide (BNP) and N-terminal B-type natriuretic peptide (NT proBNP) in diagnosing heart failure due to left ventricular systolic dysfunction in patients with suspected heart failure referred by GPs to one-stop diagnostic clinics. DESIGN OF STUDY: Community cohort, prospective, diagnostic accuracy study.
SETTING: One-stop diagnostic clinics in Darlington Memorial and Bishop Auckland General Hospitals and general practices in South Durham.
SUBJECTS: Two hundred and ninety-seven consecutive patients with symptoms and signs suggestive of heart failure referred from general practice.
METHOD: The study measured sensitivity, specificity, positive and negative predictive values (PPV, NPV), and area under receiver operating characteristic curve for BNP (near patient assay) and NT proBNP (laboratory assay) in diagnosis of heart failure due to left ventricular systolic dysfunction. The NPV of both assays was determined as a potential method of reducing the number of referrals for echocardiography.
RESULTS: One hundred and fourteen of the 297 patients had left ventricular systolic dysfunction (38%). At the manufacturer's recommended cut-off of 100 pg/ml BNP gave a NPV of 82%. BNP performed better at a cut-off of 40 pg/ml with a NPV of 88%. At a cut-off of 150 pg/ml, NT proBNP gave a NPV of 92%. Using cut-offs of 40 pg/ml and 150 pg/ml for BNP and NT pro-BNP, respectively, could have prevented 24% and 25% of referrals to the clinic, respectively.
CONCLUSIONS: In this setting, NT pro-BNP performed marginally better than BNP, and would be easier to use practically in primary care. A satisfactory cut-off has been identified, which needs validating in general practice. NT pro-BNP could be used to select referrals to a heart failure clinic or for echocardiography. This process needs testing in real-life general practice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16638247      PMCID: PMC1837840     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  40 in total

1.  Measuring brain natriuretic peptide in suspected left ventricular systolic dysfunction in general practice: cross-sectional study.

Authors:  M J Landray; R Lehman; I Arnold
Journal:  BMJ       Date:  2000-04-08

2.  European survey of primary care physician perceptions on heart failure diagnosis and management (Euro-HF).

Authors:  F D Hobbs; M I Jones; T F Allan; S Wilson; R Tobias
Journal:  Eur Heart J       Date:  2000-11       Impact factor: 29.983

3.  Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations.

Authors:  B A Groenning; J C Nilsson; L Sondergaard; A Kjaer; H B Larsson; P R Hildebrandt
Journal:  Eur J Heart Fail       Date:  2001-12       Impact factor: 15.534

4.  Guidelines for the diagnosis and treatment of chronic heart failure.

Authors:  W J Remme; K Swedberg
Journal:  Eur Heart J       Date:  2001-09       Impact factor: 29.983

5.  Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure.

Authors:  Wendy Johnson; Torbjørn Omland; Christian Hall; Caroline Lucas; Ole L Myking; Caroline Collins; Marc Pfeffer; Jean-Lucien Rouleau; Lynne W Stevenson
Journal:  J Am Coll Cardiol       Date:  2002-05-15       Impact factor: 24.094

6.  Failure of plasma brain natriuretic peptide to identify left ventricular systolic dysfunction in the community.

Authors:  D J Hetmanski; N J Sparrow; S Curtis; A J Cowley
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

7.  Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings.

Authors:  Emily Lubien; Anthony DeMaria; Padma Krishnaswamy; Paul Clopton; Jen Koon; Radmila Kazanegra; Nancy Gardetto; Erin Wanner; Alan S Maisel
Journal:  Circulation       Date:  2002-02-05       Impact factor: 29.690

8.  Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population.

Authors:  T A McDonagh; A D Cunningham; C E Morrison; J J McMurray; I Ford; J J Morton; H J Dargie
Journal:  Heart       Date:  2001-07       Impact factor: 5.994

9.  Natriuretic peptides in patients with aortic stenosis.

Authors:  W Qi; P Mathisen; J Kjekshus; S Simonsen; R Bjørnerheim; K Endresen; C Hall
Journal:  Am Heart J       Date:  2001-10       Impact factor: 4.749

10.  Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study.

Authors:  A Rossi; M Enriquez-Sarano; J C Burnett; A Lerman; M D Abel; J B Seward
Journal:  J Am Coll Cardiol       Date:  2000-04       Impact factor: 24.094

View more
  31 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

2.  Diagnosis and diagnostic testing in primary care.

Authors:  Colin McCowan; Tom Fahey
Journal:  Br J Gen Pract       Date:  2006-05       Impact factor: 5.386

3.  Screening for left ventricular systolic dysfunction using GP-reported ECGs.

Authors:  Barclay M Goudie; Rob I Jarvis; Peter T Donnan; Frank M Sullivan; Stuart D Pringle; Sanjay Jeyaseelan; Allan D Struthers
Journal:  Br J Gen Pract       Date:  2007-03       Impact factor: 5.386

Review 4.  CSI position statement on management of heart failure in India.

Authors:  Santanu Guha; S Harikrishnan; Saumitra Ray; Rishi Sethi; S Ramakrishnan; Suvro Banerjee; V K Bahl; K C Goswami; Amal Kumar Banerjee; S Shanmugasundaram; P G Kerkar; Sandeep Seth; Rakesh Yadav; Aditya Kapoor; Ajaykumar U Mahajan; P P Mohanan; Sundeep Mishra; P K Deb; C Narasimhan; A K Pancholia; Ajay Sinha; Akshyaya Pradhan; R Alagesan; Ambuj Roy; Amit Vora; Anita Saxena; Arup Dasbiswas; B C Srinivas; B P Chattopadhyay; B P Singh; J Balachandar; K R Balakrishnan; Brian Pinto; C N Manjunath; Charan P Lanjewar; Dharmendra Jain; Dipak Sarma; G Justin Paul; Geevar A Zachariah; H K Chopra; I B Vijayalakshmi; J A Tharakan; J J Dalal; J P S Sawhney; Jayanta Saha; Johann Christopher; K K Talwar; K Sarat Chandra; K Venugopal; Kajal Ganguly; M S Hiremath; Milind Hot; Mrinal Kanti Das; Neil Bardolui; Niteen V Deshpande; O P Yadava; Prashant Bhardwaj; Pravesh Vishwakarma; Rajeeve Kumar Rajput; Rakesh Gupta; S Somasundaram; S N Routray; S S Iyengar; G Sanjay; Satyendra Tewari; Sengottuvelu G; Soumitra Kumar; Soura Mookerjee; Tiny Nair; Trinath Mishra; U C Samal; U Kaul; V K Chopra; V S Narain; Vimal Raj; Yash Lokhandwala
Journal:  Indian Heart J       Date:  2018-06-08

5.  Point-of-care B-type natriuretic peptide and portable echocardiography for assessment of patients with suspected heart failure in primary care: rationale and design of the three-part Handheld-BNP program and results of the training study.

Authors:  Caroline Morbach; Thomas Buck; Christian Rost; Sebastian Peter; Stephan Günther; Stefan Störk; Christiane Prettin; Raimund Erbel; Georg Ertl; Christiane E Angermann
Journal:  Clin Res Cardiol       Date:  2017-11-15       Impact factor: 5.460

6.  What the General Practitioner Needs to Know About Their Chronic Heart Failure Patient.

Authors:  Frans H Rutten; Joe Gallagher
Journal:  Card Fail Rev       Date:  2016-11

7.  In-hospital and long-term outcomes of congestive heart failure: Predictive value of B-type and amino-terminal pro-B-type natriuretic peptides and their ratio.

Authors:  Yuxiang Dai; Jun Yang; Atsutoshi Takagi; Hakuoh Konishi; Tetsuro Miyazaki; Hiroshi Masuda; Kazunori Shimada; Katsumi Miyauchi; Hiroyuki Daida
Journal:  Exp Ther Med       Date:  2017-06-27       Impact factor: 2.447

8.  Prospective evaluation and long-term follow-up of patients referred to secondary care based upon natriuretic peptide levels in primary care.

Authors:  John Gierula; Richard M Cubbon; Maria F Paton; Rowenna Byrom; Judith E Lowry; Sarah F Winsor; Melanie McGinlay; Emma Sunley; Emma Pickles; Lorraine C Kearney; Aaron Koshy; Thomas A Slater; Hemant K Chumun; Haqeel A Jamil; Kristian M Bailey; Julian H Barth; Mark T Kearney; Klaus K Witte
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2019-07-01

9.  Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review.

Authors:  Ronald A Booth; Stephen A Hill; Andrew Don-Wauchope; P Lina Santaguida; Mark Oremus; Robert McKelvie; Cynthia Balion; Judy A Brown; Usman Ali; Amy Bustamam; Nazmul Sohel; Parminder Raina
Journal:  Heart Fail Rev       Date:  2014-08       Impact factor: 4.214

10.  Natriuretic Peptide testing in primary care.

Authors:  Shafiq U Rehman; James L Januzzi
Journal:  Curr Cardiol Rev       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.